HCA Healthcare, Inc. (NYSE:HCA) Stake Lessened by Pinnacle Financial Partners Inc

Pinnacle Financial Partners Inc trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 253,595 shares of the company's stock after selling 2,244 shares during the period. HCA Healthcare accounts for about 1.6% of Pinnacle Financial Partners Inc's investment portfolio, making the stock its 11th largest position. Pinnacle Financial Partners Inc owned about 0.10% of HCA Healthcare worth $81,129,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC grew its stake in HCA Healthcare by 26.9% in the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after acquiring an additional 242 shares during the last quarter. Oppenheimer Asset Management Inc. raised its position in shares of HCA Healthcare by 2.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock valued at $1,491,000 after buying an additional 105 shares during the last quarter. GAMMA Investing LLC raised its position in shares of HCA Healthcare by 17.6% in the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock valued at $1,704,000 after buying an additional 737 shares during the last quarter. Brighton Jones LLC acquired a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $1,021,000. Finally, OLD National Bancorp IN raised its position in shares of HCA Healthcare by 5.2% in the first quarter. OLD National Bancorp IN now owns 1,049 shares of the company's stock valued at $362,000 after buying an additional 52 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 1.4%

Shares of HCA traded down $5.20 during mid-day trading on Friday, reaching $372.84. 943,125 shares of the stock traded hands, compared to its average volume of 1,461,363. The firm has a market cap of $89.69 billion, a price-to-earnings ratio of 16.58, a P/E/G ratio of 1.31 and a beta of 1.47. The stock has a fifty day simple moving average of $370.64 and a 200 day simple moving average of $338.65. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the firm posted $5.36 earnings per share. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were paid a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.77%. HCA Healthcare's dividend payout ratio is currently 12.81%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of analyst reports. Robert W. Baird reissued a "neutral" rating and issued a $336.00 price objective (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Royal Bank Of Canada reiterated an "outperform" rating and set a $404.00 price objective (up from $376.00) on shares of HCA Healthcare in a report on Monday, June 23rd. Morgan Stanley set a $410.00 price objective on shares of HCA Healthcare and gave the stock an "equal weight" rating in a report on Monday, June 9th. Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the stock from $320.00 to $385.00 in a report on Thursday, May 29th. Finally, Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Eight investment analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $395.71.

Insider Activity

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.